Improving Adherence to Inhaled Therapy in Adults with COPD and Bronchial Asthma Using Education and Artificial Intelligence Tools

What this Trial Is About

This research aims to address the widespread problem of not following inhaled therapy properly in patients with bronchial asthma and chronic obstructive pulmonary disease COPD. The study focuses on assessing how well patients adhere to their inhaled treatments and evaluates the knowledge and skills of healthcare professionals who care for these patients. It uses a validated tool called the Five Steps Assessment FSA along with artificial intelligence methods to support this effort across multiple healthcare settings. Participants include outpatients and nursing home residents with bronchial asthma or COPD, as well as healthcare professionals. The study will develop and implement a mobile and web-based app using artificial intelligence to assist both patients and providers. Interventions for patients involve training on correct inhalation techniques, educational materials, and remote contacts through phone or online platforms. Healthcare professionals will receive courses including e-learning and app-based education to improve their inhalation technique skills. During the study, adherence to inhaled treatments will be measured repeatedly over 12 months using the FSA tool and the Medication Adherence Report Scale MARS. Healthcare professionals knowledge and skills will also be evaluated using questionnaires and the FSA. Clinical and laboratory biomarkers indicating disease stability will be assessed in a subgroup. The study will monitor how these interventions impact adherence and care quality, with the overall participation lasting up to one year.

Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma